ArticleScience China. Life sciences2026
Virulensome: a transient organelle mediating fungal virulence.
Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal pathogens utilize specialized cellular systems to overcome host defenses, yet no dedicated pathogenic organelles have been previously defined in fungi. Here, we describe a transient, membrane-bound vesicle (100-250 nm in diameter) that forms specifically within the infection structures of a nematode-trapping fungus Dactylellina haptotyla, which we term the virulensome. Density-gradient isolation yielded virulensome-enriched fractions that killed 81.6% of Caenorhabditis elegans larvae within 24 h and perforated the nematode cuticle. Quantitative proteomics revealed 486 core components, including 31 peptidases and 23 glycoside hydrolases. Knockout of each of three representative proteins-an α-mannosidase (DHGH1), a metalloendopeptidase (DHMEPE1), and a WSC-domain protein-reduced virulensome abundance by up to 80% and lowered nematode mortality by 4-fold. Conversely, recombinant DHGH1 or DHMEPE1 killed >90% of nematodes in vitro. Live-cell super-resolution imaging showed virulensomes polarizing toward the host interface, disintegrating within infection bulbs, and releasing toxic effector cargos into the nematode body. These findings define the virulensome that packages and delivers destructive enzymes in a targeted manner, revealing a previously unrecognized mechanism of pathogenesis.
Indexed as
Identifiers
42301561What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.